oxybutynin has been researched along with Actinic Keratosis in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dattola, A | 1 |
Gutiérrez Garcìa-Rodrigo, C | 1 |
Tambone, S | 1 |
Garofalo, V | 1 |
Lappi, A | 1 |
De Luca, EV | 1 |
Peris, K | 1 |
Bianchi, L | 1 |
Campione, E | 1 |
Fargnoli, MC | 1 |
Braathen, LR | 1 |
Szeimies, RM | 1 |
Hauschild, A | 1 |
Ortland, C | 1 |
Moor, AC | 1 |
Stocker, M | 1 |
Surber, C | 1 |
3 other studies available for oxybutynin and Actinic Keratosis
Article | Year |
---|---|
5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Italy; Keratosis, Actinic; Levulinic A | 2020 |
Successful Daylight-PDT using a self-adhesive 5-aminolaevulinic acid patch.
Topics: Adhesives; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Male; Photochemothera | 2018 |
Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Topics: Aminolevulinic Acid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans | 2015 |